Bulitic, Lloyd .

HRN: 28-62-00  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/24/2026
CEFUROXIME 750MG (VIAL)
02/24/2026
03/02/2026
IV
700mg
Q8
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: